MENU
MNKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MannKind (MNKD) Earnings Date & Reports

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 47.50% to 4 cents per share on May 07

MannKind MNKD Stock Earnings Reports
Q1'25
Est.
$0.04
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.01
The last earnings report on February 26 showed earnings per share of 7 cents, beating the estimate of 2 cents. With 993.13K shares outstanding, the current market capitalization sits at 1.52B.
View a ticker or compare two or three
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com